Nucleic acid therapies: Towards cardiac-specific recombinant adeno-associated viruses (rAAVs) of human origin: Directed evolution and characterization of novel AAV variants isolated from human failing hearts in models with human relevance and relevance fo
| Institution | Universitätsklinikum Hamburg-Eppendorf (UKE) |
|---|---|
| Projektleiter | Arne Hansen |
| Standort | Hamburg/Kiel/Lübeck |
| Projektart | Innovation Cluster |
| Fördersumme | € 206.542,00 |
| Beginn | 01.01.2021 |
| Ende | 31.12.2025 |
| Partnerprojekte |
|
Förderkennzeichen
81X2710183
Projektnummer
1315